27 Mar
Dose-Conversion Ratio for Epoetin Alfa: METHODS
Study Population This secondary retrospective analysis used data from an open-label, randomized, multicenter, head-to-head trial comparing EPO and DARB. To be included in the trial, patients had to be histologically confirmed solid malignancy baseline hemoglobin level of 11 g/dl or lower cyclic chemotherapy scheduled for a minimum of 12 weeks informed consent obtained fewer than [...]